Want to see AU:TRI full AI Analyst Report?
TRI Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume234.85K
Average Volume (3M)774.84K
Market Cap
AU$9.23M
Enterprise ValueAU$21.91M
Total Cash (Recent Filing)AU$2.44M
Total Debt (Recent Filing)AU$128.14K
Price to Earnings (P/E)―
Beta2.32
Next Earnings
Feb 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.95
Shares Outstanding1,153,693,500
10 Day Avg. Volume393,973
30 Day Avg. Volume774,835
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.01
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageMinimal debt relative to equity reduces near-term solvency pressure and limits mandatory interest or repayment demands. This gives TrivarX greater balance-sheet flexibility while it addresses operating weaknesses, although low leverage alone does not establish a path to profitability.
Asset Base ExpansionGrowth in total assets indicates that the company’s balance-sheet resources expanded year over year. A larger asset base may provide more capacity to support operations and strategic development over the next several quarters, provided those resources are used productively.
Limited Debt BurdenA limited debt burden reduces exposure to refinancing pressure and makes the company less dependent on creditors than a highly leveraged business. That structure can preserve financial optionality through a difficult operating period, even though ongoing losses remain a material constraint.
Bears Say
No Reported RevenueThree consecutive years of zero reported revenue provide no demonstrated revenue engine in the financial statements and leave the cost base uncovered. Without visible sales generation, durable operating scale and future self-funded growth remain unestablished over the next several quarters.
Widening LossesThe sharp deterioration in net and operating losses signals that the current cost structure is not moving toward profitability. If this pattern persists, it can erode equity, weaken returns for shareholders, and increase the need for corrective action or additional funding.
Persistent Cash BurnNegative operating cash flow across all reported years, combined with the 2026 step-down, shows that operations are consuming rather than generating cash. Continued burn can reduce available resources and leave the company dependent on external funding or balance-sheet support.
TrivarX Limited News
TRI FAQ
What was TrivarX Limited’s price range in the past 12 months?
TrivarX Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is TrivarX Limited’s market cap?
TrivarX Limited’s market cap is AU$9.23M.
When is TrivarX Limited’s upcoming earnings report date?
TrivarX Limited’s upcoming earnings report date is Feb 19, 2027 which is in 114 days.
How were TrivarX Limited’s earnings last quarter?
TrivarX Limited released its earnings results on Aug 27, 2026. The company reported -AU$0.954 earnings per share for the quarter.
Is TrivarX Limited overvalued?
According to Wall Street analysts TrivarX Limited’s price is currently Overvalued.
Does TrivarX Limited pay dividends?
TrivarX Limited does not currently pay dividends.
What is TrivarX Limited’s EPS estimate?
TrivarX Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TrivarX Limited have?
TrivarX Limited has 1,153,693,500 shares outstanding.
What happened to TrivarX Limited’s price movement after its last earnings report?
TrivarX Limited reported an EPS of -AU$0.954 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TrivarX Limited?
Currently, no hedge funds are holding shares in AU:TRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TrivarX Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:TRI Sentiment 100%
Sector Average 66%
Sector Average 66%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-44.34%
Trailing 12-Months
Asset Growth
29.64%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
TrivarX Limited
Operating as a health technology enterprise, TrivarX Limited specializes in crafting artificial intelligence-driven, scientifically validated instruments designed for the assessment and identification of behavioral health disorders. Its market presence extends across Australia and the United States. The company delivers mental well-being provisions tailored for corporate clients through its enterprise health offerings, concurrently developing solutions for medical service providers. Established in 1987, the entity was formerly known as Medibio Limited until its rebranding as TrivarX Limited in October 2023. Its principal place of business is situated in Mount Lawley, Australia.
Technical Analysis
Resonance Health Ltd
―
Opyl Ltd.
―
MedAdvisor Limited
―
InteliCare Holdings Limited
―
PainChek Ltd
―